New York State Common Retirement Fund Boosts Holdings in OraSure Technologies, Inc. (OSUR)

New York State Common Retirement Fund raised its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 31.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 498,494 shares of the medical instruments supplier’s stock after acquiring an additional 119,627 shares during the quarter. New York State Common Retirement Fund’s holdings in OraSure Technologies were worth $5,822,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of OraSure Technologies by 2.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,886,966 shares of the medical instruments supplier’s stock worth $44,604,000 after purchasing an additional 58,307 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of OraSure Technologies by 2.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 759,600 shares of the medical instruments supplier’s stock worth $12,510,000 after purchasing an additional 16,089 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. boosted its position in shares of OraSure Technologies by 154.0% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 124,643 shares of the medical instruments supplier’s stock worth $1,926,000 after purchasing an additional 75,580 shares in the last quarter. American Capital Management Inc. boosted its position in shares of OraSure Technologies by 275.5% in the 4th quarter. American Capital Management Inc. now owns 1,720,032 shares of the medical instruments supplier’s stock worth $20,090,000 after purchasing an additional 1,262,015 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of OraSure Technologies by 352.3% in the 3rd quarter. Morgan Stanley now owns 1,290,002 shares of the medical instruments supplier’s stock worth $19,930,000 after purchasing an additional 1,004,774 shares in the last quarter. 91.83% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts have recently commented on the company. Canaccord Genuity reissued a “buy” rating and issued a $16.00 price target on shares of OraSure Technologies in a research report on Thursday, February 7th. ValuEngine cut OraSure Technologies from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, BidaskClub raised OraSure Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $16.50.

Shares of OSUR opened at $11.33 on Friday. OraSure Technologies, Inc. has a 52 week low of $9.15 and a 52 week high of $18.71. The company has a market capitalization of $698.61 million, a PE ratio of 22.66, a P/E/G ratio of 3.00 and a beta of 1.27.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Wednesday, February 6th. The medical instruments supplier reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.09. OraSure Technologies had a net margin of 11.22% and a return on equity of 8.45%. The company had revenue of $50.25 million during the quarter, compared to analyst estimates of $47.77 million. During the same period in the previous year, the business earned $0.12 EPS. The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. On average, research analysts predict that OraSure Technologies, Inc. will post 0.3 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “New York State Common Retirement Fund Boosts Holdings in OraSure Technologies, Inc. (OSUR)” was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://sportsperspectives.com/2019/03/15/new-york-state-common-retirement-fund-boosts-holdings-in-orasure-technologies-inc-osur.html.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

Recommended Story: Cost of Capital Explained

Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.